Citation Impact
Citing Papers
Transferred WT1-Reactive CD8 + T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients
2013
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
2011 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Inadequate Antimicrobial Treatment of Infections
1999 Standout
Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe
2002
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
2014 Standout
Dasatinib
2009
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey
2002
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Chronic myelogenous leukemia
2001
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
A simulation study of the number of events per variable in logistic regression analysis
1996 Standout
Risk assessment in haemotopoietic stem cell transplantation: Disease and disease stage
2007
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Allogeneic Hematopoietic Progenitor Cell Transplantation for the Treatment of Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitors: Lessons Learned to Date
2007
The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU Setting
2000 Standout
Current approach to the treatment of chronic myeloid leukaemia
2017
Chronic graft-versus-host disease
2003 Standout
Cancer genes and the pathways they control
2004 Standout
Graft-versus-host disease
2009 Standout
Graft-versus-Host Disease, the Graft-versus-Leukemia Effect, and Mixed Chimerism following Nonmyeloablative Stem Cell Transplantation
2003
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Chronic Myelogenous Leukemia
2002
Hematopoietic Stem-Cell Transplantation
2006 Standout
Molecular remission of chronic myeloid leukaemia following a non‐myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft‐versus‐leukaemia effect
1999
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Risk score for outcome after allogeneic hematopoietic stem cell transplantation
2009
Complications of Endoscopic Biliary Sphincterotomy
1996 Standout
Endotoxin antagonism: conceptual basis and therapeutic potential
2002 StandoutNobel
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial
1999 Standout
Imatinib Mesylate — A New Oral Targeted Therapy
2002
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
2011 Standout
Non-HLA immunogenetics in hematopoietic stem cell transplantation
2005
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation
2001
Association of SIGNR1 with TLR4–MD-2 enhances signal transduction by recognition of LPS in gram-negative bacteria
2005 StandoutNobel
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
2006
Risk assessment in haematopoietic stem cell transplantation: Pre–transplant patient and donor factors: non-HLA genetics
2007
STI571: A Paradigm of New Agents for Cancer Therapeutics
2002
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Acute Myeloid Leukemia
2015 Standout
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities
2004
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Biology of Gastrointestinal Stromal Tumors
2004 Standout
Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT
2005
Determinants of disparities between perceived and physiological risk of falling among elderly people: cohort study.
2010 Standout
Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies
1987
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
2005 Standout
Improved disease-free–survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia
2002
Cancer treatment and survivorship statistics, 2016
2016 Standout
The Risk of Determining Risk with Multivariable Models
1993 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Diagnosing and Managing Advanced Chronic Myeloid Leukemia
2015
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Large-scale analysis of the human and mouse transcriptomes
2002 StandoutNobel
Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia
2020 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Chronic myeloid leukemia: current treatment options
2001
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
STI571: A Paradigm of New Agents for Cancer Therapeutics
2002
Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell Transplantation
2014
Works of J. Apperley being referenced
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation
1998
ANTIBODY TITRES TO A ROUGH-MUTANT STRAIN OF ESCHERICHIA COLI IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
1987